ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors

April 25, 1980

Foundations: Lasker Awards honor Work In Nitric Oxide, HIB Vaccine

October 4, 1996

NCCS Networker Volume 2 Issue 3, Summer 1988

June 13, 1988

NCI-Funded Modelers Accurately Predicted Outcome Of Lung Cancer Screening Trial

November 26, 2010

Definitions, New Categories Of Centers Suggested By Cantril

July 2, 1976

NCI Panel Urges Smaller Pilot Trials In Pancreatic Cancer

November 6, 2009